Clinical Trial: AML Therapy With Irradiated Allogeneic Cells

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: AML Therapy With Irradiated Allogeneic Cells

Brief Summary: This pilot clinical trial studies if cells donated by a close genetic relative can help keep acute myeloid leukemia (AML) from coming back after standard chemotherapy induces a complete remission. Blood cells obtained from a donor include a variety of blood cells that may trigger the patient's immune system to react against AML cells.